UK Companies Partner On COVID-19 Antibody Test

Mologic’s COVID-19 lateral flow test has been combined with a kit designed by BioSure to create a COVID-19 antibody self-test that can be used without any training. Requiring only a fraction of a drop of blood, gives the user their own result in just 10 minutes.

The BioSURE COVID-19 Antibody Self-Test, expected to be ready for mass production at the beginning of June, will be available to the UK and global markets and for direct purchase.

Mark Davis, CEO, Mologic said: “Mologic is thrilled to be partnering with BioSure on this COVID-19 self-test, which will enable people to quickly and safely test for antibodies to the virus in their own home. The team and our independent validation partners have worked tirelessly to develop and optimise this quality rapid diagnostic in record time and this partnership brings it one step closer getting it on the market. To all those that have contributed to this project and supported us thus far, I offer my sincere gratitude.”

Brigette Bard, CEO of BioSure added: “We are incredibly proud to announce our partnership with Mologic, the world-leading scientific researchers. Our companies are very aligned in their dynamic thinking and the way we both have a strong passion to find solutions to problems. Their expertise and creativity mean that together we have an outstanding test, that everyone, everywhere, will be able to test on their own terms. I cannot thank them enough for their phenomenal approach and extraordinary hard work and I would also like to thank the general public for their unwavering support. Our companies have already developed life-saving diagnostics across our individual product portfolios, including HIV and Ebola, and jointly we can now continue to accelerate our impact by putting the test into the end users’ hands, who will get their own result while they wait.”